A Prehabilitation Program to Boost Postoperative Functional Capacity in Surgical Lung Cancer Patients

NCT ID: NCT04826835

Last Updated: 2024-01-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

198 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-05-14

Study Completion Date

2025-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This research study is evaluating a prehabiliation intervention designed to improve postoperative functional capacity (measured by 6-minure walking distance) in individuals undergoing lung resection for cancer.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Prehabilitation intervention

Participants in the intervention group will follow a 2-week prehabilitation program before lung resection.

Group Type EXPERIMENTAL

Prehabilitation intervention

Intervention Type BEHAVIORAL

Participants will:

* Receive four supervised exercise classes (twice per week for two weeks) one-to-one by an exercise specialist;
* Practice six sessions of home-based exercise (three times per week for two weeks);
* Practice unsupervised respiratory muscle training at home (twice daily for two weeks);
* Receive usual care.

Health education control

Participants in the control group will receive health education classes during 2 weeks before lung resection.

Group Type ACTIVE_COMPARATOR

Health education control

Intervention Type BEHAVIORAL

Participants will:

* Receive four recorded health education talks (twice per week for two weeks)
* Receive a brief health education booklet on dietary education for chronic lung conditions, preoperative preparation, and postoperative recovery
* Receive usual care.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Prehabilitation intervention

Participants will:

* Receive four supervised exercise classes (twice per week for two weeks) one-to-one by an exercise specialist;
* Practice six sessions of home-based exercise (three times per week for two weeks);
* Practice unsupervised respiratory muscle training at home (twice daily for two weeks);
* Receive usual care.

Intervention Type BEHAVIORAL

Health education control

Participants will:

* Receive four recorded health education talks (twice per week for two weeks)
* Receive a brief health education booklet on dietary education for chronic lung conditions, preoperative preparation, and postoperative recovery
* Receive usual care.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients who are diagnosed of stage I, II, or IIIA Non-small-cell lung carcinoma (NSCLC) diagnosis, with or without pre-operative histologic confirmation
2. Patients scheduled to undergo lung resection surgery at least two weeks from recruitment
3. Patients with a Eastern Cooperative Oncology Group (ECOG) score of 0 or 1 at recruitment
4. Patients with no evidence of recurrent or progressive disease
5. Patients aged 45-80 years
6. Patients able to communicate in Cantonese, Mandarin, or English
7. Patients is absence of any cognitive impairment
8. Patients with a score of 6 minutes walking test (6MWT) ≤ 500 meters at baseline. \[rationale: a threshold value of 500 meters preoperative 6MWT predicts a higher risk of postoperative complications and prolonged LOS after lung resection\]
9. Engagement in less than 150 minutes of moderate aerobic activity per week in the past 3 months

Exclusion Criteria

1. Patients who had engaged in at least 150 minutes of moderate aerobic activity or 75 minutes of vigorous aerobic activity per week in the past three months
2. Presence of another concurrent, actively treated malignancy
3. Presence of chronic obstructive pulmonary disease
4. Presence of significant comorbidities that impede ability to engage in exercise, such as congestive heart failure, orthopedic disorders of the lower limbs, respiratory failure, or the need for portable oxygen therapy for activities of daily living
5. Not having a smart device to receive WhatsApp messages
Minimum Eligible Age

45 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The University of Hong Kong

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Professor Chia-Chin Lin

Professor and Head

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Queen Mary Hospital

Hong Kong, , Hong Kong

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Hong Kong

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Chia-chin Lin, PhD

Role: CONTACT

Xinyi Xu, BSN

Role: CONTACT

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UW 19-214

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.